Drug
Deferoxamine Mesylate
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Sickle Cell Anaemia With Crisis | 46 | 28.8 | 29.4 | signal |
| 2 | Agranulocytosis | 49 | 26.2 | 26.8 | signal |
| 3 | Splenomegaly | 27 | 22.8 | 23.1 | signal |
| 4 | Myelodysplastic Syndrome | 30 | 20.5 | 20.8 | signal |
| 5 | Hepatomegaly | 18 | 18.0 | 18.2 | signal |
| 6 | Visual Acuity Reduced | 48 | 14.2 | 14.5 | signal |
| 7 | Blood Urea Increased | 23 | 13.5 | 13.6 | signal |
| 8 | Haematocrit Decreased | 27 | 13.4 | 13.5 | signal |
| 9 | Blood Creatinine Increased | 81 | 12.2 | 12.7 | signal |
| 10 | Blood Lactate Dehydrogenase Increased | 19 | 11.8 | 11.9 | signal |
| 11 | Haemoglobin Decreased | 121 | 11.6 | 12.3 | signal |
| 12 | Acute Myeloid Leukaemia | 18 | 11.4 | 11.5 | signal |
| 13 | Transfusion | 12 | 11.3 | 11.3 | signal |
| 14 | Multi-organ Failure | 20 | 11.3 | 11.4 | signal |
| 15 | Caesarean Section | 13 | 10.9 | 11.0 | signal |
| 16 | Transaminases Increased | 23 | 10.2 | 10.3 | signal |
| 17 | Polyneuropathy | 12 | 10.0 | 10.0 | signal |
| 18 | Ejection Fraction Decreased | 15 | 9.5 | 9.6 | signal |
| 19 | Pulmonary Hypertension | 20 | 9.4 | 9.5 | signal |
| 20 | Infusion Site Pain | 12 | 9.3 | 9.3 | signal |
| 21 | Bone Marrow Failure | 19 | 9.2 | 9.2 | signal |
| 22 | Blood Bilirubin Increased | 25 | 9.1 | 9.2 | signal |
| 23 | Obstructive Airways Disorder | 10 | 8.8 | 8.9 | signal |
| 24 | Neutrophil Count Decreased | 36 | 8.8 | 8.9 | signal |
| 25 | Macular Degeneration | 10 | 8.3 | 8.3 | signal |
| 26 | Hepatic Failure | 25 | 8.2 | 8.3 | signal |
| 27 | Cardiomyopathy | 12 | 8.0 | 8.0 | signal |
| 28 | Chromaturia | 18 | 7.9 | 7.9 | signal |
| 29 | Hepatic Function Abnormal | 29 | 7.7 | 7.8 | signal |
| 30 | Coagulopathy | 13 | 7.7 | 7.8 | signal |
| 31 | Prescribed Overdose | 15 | 7.7 | 7.7 | signal |
| 32 | Liver Disorder | 34 | 7.6 | 7.7 | signal |
| 33 | Alanine Aminotransferase Increased | 47 | 7.6 | 7.7 | signal |
| 34 | Metabolic Acidosis | 24 | 7.5 | 7.6 | signal |
| 35 | Multiple Organ Dysfunction Syndrome | 21 | 7.4 | 7.5 | signal |
| 36 | Nephrolithiasis | 34 | 7.3 | 7.4 | signal |
| 37 | Acute Hepatic Failure | 10 | 7.3 | 7.3 | signal |
| 38 | Red Blood Cell Count Decreased | 21 | 7.2 | 7.3 | signal |
| 39 | Deafness | 19 | 7.2 | 7.2 | signal |
| 40 | Pharyngitis | 9 | 7.1 | 7.2 | signal |
| 41 | Gamma-glutamyltransferase Increased | 16 | 7.1 | 7.2 | signal |
| 42 | C-reactive Protein Increased | 26 | 7.1 | 7.1 | signal |
| 43 | Mitral Valve Incompetence | 8 | 7.0 | 7.0 | signal |
| 44 | Jaundice | 19 | 7.0 | 7.0 | signal |
| 45 | White Blood Cell Count Increased | 27 | 6.9 | 7.0 | signal |
| 46 | Bacterial Infection | 13 | 6.9 | 6.9 | signal |
| 47 | Proteinuria | 13 | 6.8 | 6.8 | signal |
| 48 | Blood Alkaline Phosphatase Increased | 17 | 6.7 | 6.8 | signal |
| 49 | Petechiae | 7 | 6.6 | 6.7 | signal |
| 50 | Septic Shock | 29 | 6.6 | 6.7 | signal |
| 51 | Hepatitis C | 8 | 6.5 | 6.5 | signal |
| 52 | Retinal Detachment | 6 | 6.4 | 6.5 | signal |
| 53 | Generalised Oedema | 8 | 6.4 | 6.4 | signal |
| 54 | Liver Function Test Abnormal | 19 | 6.4 | 6.5 | signal |
| 55 | Device Related Infection | 10 | 6.4 | 6.4 | signal |
| 56 | Cardiac Failure | 52 | 6.4 | 6.5 | signal |
| 57 | Hepatic Encephalopathy | 6 | 6.3 | 6.4 | signal |
| 58 | Lymphopenia | 9 | 6.3 | 6.3 | signal |
| 59 | Drug Exposure During Pregnancy | 22 | 6.3 | 6.4 | signal |
| 60 | Leukaemia | 6 | 6.3 | 6.3 | signal |
| 61 | Pancytopenia | 34 | 6.0 | 6.1 | signal |
| 62 | Treatment Noncompliance | 33 | 6.0 | 6.1 | signal |
| 63 | Cytomegalovirus Infection | 10 | 5.9 | 6.0 | signal |
| 64 | Renal Impairment | 50 | 5.9 | 6.0 | signal |
| 65 | Cholecystitis | 7 | 5.8 | 5.8 | signal |
| 66 | Acute Respiratory Distress Syndrome | 10 | 5.6 | 5.6 | signal |
| 67 | White Blood Cell Count Decreased | 60 | 5.5 | 5.6 | signal |
| 68 | Drug-induced Liver Injury | 17 | 5.4 | 5.5 | signal |
| 69 | Skin Infection | 6 | 5.3 | 5.3 | signal |
| 70 | Toxic Epidermal Necrolysis | 8 | 5.2 | 5.3 | signal |
| 71 | Blindness | 21 | 5.1 | 5.1 | signal |
| 72 | Febrile Neutropenia | 34 | 5.1 | 5.1 | signal |
| 73 | Viral Infection | 17 | 5.0 | 5.1 | signal |
| 74 | Blood Iron Decreased | 6 | 5.0 | 5.0 | signal |
| 75 | Lymphocyte Count Decreased | 9 | 5.0 | 5.0 | signal |
| 76 | Skin Reaction | 7 | 4.9 | 4.9 | signal |
| 77 | Disseminated Intravascular Coagulation | 7 | 4.9 | 4.9 | signal |
| 78 | Cholestasis | 9 | 4.7 | 4.7 | signal |
| 79 | Platelet Count Decreased | 50 | 4.6 | 4.7 | signal |
| 80 | Premature Baby | 14 | 4.6 | 4.6 | signal |
| 81 | Leukopenia | 23 | 4.6 | 4.6 | signal |
| 82 | Pallor | 12 | 4.3 | 4.4 | signal |
| 83 | Neoplasm | 5 | 4.3 | 4.3 | signal |
| 84 | Dialysis | 6 | 4.2 | 4.2 | signal |
| 85 | Face Oedema | 7 | 4.1 | 4.1 | signal |
| 86 | Neutropenia | 55 | 4.0 | 4.1 | signal |
| 87 | Toxic Skin Eruption | 4 | 3.9 | 3.9 | signal |
| 88 | Subarachnoid Haemorrhage | 4 | 3.9 | 3.9 | signal |
| 89 | Ear Discomfort | 4 | 3.9 | 3.9 | signal |
| 90 | Blood Count Abnormal | 6 | 3.9 | 3.9 | signal |
| 91 | Scratch | 4 | 3.8 | 3.8 | signal |
| 92 | Platelet Count Increased | 5 | 3.8 | 3.8 | signal |
| 93 | Red Blood Cell Sedimentation Rate Increased | 4 | 3.6 | 3.6 | signal |
| 94 | Neurotoxicity | 6 | 3.4 | 3.4 | signal |
| 95 | Cardiac Failure Congestive | 26 | 3.2 | 3.2 | signal |
| 96 | Anorexia | 4 | 3.0 | 3.0 | no signal |
| 97 | Helicobacter Infection | 3 | 2.9 | 2.9 | no signal |
| 98 | Drug Toxicity | 4 | 2.9 | 2.9 | no signal |
| 99 | Plasma Cell Myeloma | 11 | 2.8 | 2.8 | signal |
| 100 | Osteonecrosis Of Jaw | 7 | 2.8 | 2.8 | signal |
| 101 | Nephropathy Toxic | 3 | 2.7 | 2.7 | no signal |
| 102 | Product Availability Issue | 6 | 2.6 | 2.6 | signal |
| 103 | Haemorrhage Intracranial | 4 | 2.6 | 2.6 | no signal |
| 104 | Pharmaceutical Product Complaint | 7 | 2.6 | 2.6 | signal |
| 105 | Myocarditis | 3 | 2.6 | 2.6 | no signal |
| 106 | Cytopenia | 3 | 2.5 | 2.5 | no signal |
| 107 | Premature Delivery | 4 | 2.5 | 2.5 | no signal |
| 108 | Poisoning | 3 | 2.3 | 2.3 | no signal |
| 109 | Injection Site Rash | 6 | 2.0 | 2.0 | no signal |
| 110 | Foetal Exposure During Pregnancy | 15 | 1.8 | 1.8 | no signal |
| 111 | Injection Site Reaction | 12 | 1.7 | 1.7 | no signal |
| 112 | Abortion Spontaneous | 5 | 1.2 | 1.2 | no signal |
| 113 | Injection Site Erythema | 14 | 1.1 | 1.1 | no signal |
| 114 | Intentional Overdose | 7 | 1.1 | 1.1 | no signal |